RESUMO
This article is a biopsychosocial proposal about improvement of resilience to diseases, including the COVID-19, due to affective attachment between humans and dogs. Resilience concerns the physical and emotional human capacity to respond positively to the adverse events such as diseases. Recently, some authors have proposed independent hypotheses about role of oxytocin (OT) and crossed immunity to increase the psychological resilience and immune response against the COVID-19. This text extends the hypothesis to a biopsychosocial field, including the well-known benefits of the human-dog affective attachment on human health. And proposes that a strong and reciprocal affection between human and dog can increase the resilience and resistance to COVID-19, due the role of OT in the immune response, adding to crossed immunity. Other benefits such as emotional buffering, mental comfort and stress alleviation are adjunctive roles of dogs on human health and vice-versa.
Este artículo es una propuesta biopsicosocial sobre la mejora de la resiliencia a enfermedades, incluida la COVID-19, debido al apego afectivo entre humanos y perros. La resiliencia se refiere a la capacidad humana física y emocional de responder positivamente a los eventos adversos, como las enfermedades. Recientemente, algunos autores han propuesto hipótesis independientes sobre el papel de la oxitocina (OT) y la inmunidad cruzada para aumentar la resiliencia y la respuesta frente a la COVID-19. Aquí se extiende esa hipótesis al campo biopsicosocial, incluyendo los bien conocidos beneficios del apego afectivo humano-perro sobre la salud humana. Se propone que las relaciones de afecto fuerte y recíproco entre humanos y perros pueden aumentar la resiliencia a la COVID-19, debido al papel de la OT en la respuesta inmune, sumando inmunidad cruzada. Otros beneficios como amortiguar el efecto de las emociones, la comodidad mental y el alivio del estrés son funciones complementarias de los perros en la salud humana y viceversa.
Este artigo é uma proposta biopsicossocial sobre a melhora da resiliência a doenças, incluindo a COVID-19, devido ao apego afetivo entre humanos e cães. A resiliência diz respeito à capacidade física e emocional do ser humano de responder positivamente aos eventos adversos, como as doenças. Recentemente, alguns autores propuseram hipóteses independentes sobre o papel da oxitocina (OT) e da imunidade cruzada para aumentar a resiliência e a resposta contra o COVID-19. Estende-se a hipótese a um campo biopsicossocial, incluindo os benefícios bem conhecidos do apego afetivo humano-cão à saúde humana. É proposto que as relações de afeto recíproco e forte entre humanos e cães podem aumentar a resiliência ao COVID-19, devido ao papel do OT na resposta imune, somando-se à imunidade cruzada. Outros benefícios, como proteção emocional, conforto mental e alívio do estresse são funções auxiliares dos cães na saúde humana e vice-versa.
RESUMO
In the present study, we investigated the protection conferred by a live attenuated Salmonella enterica serovar Typhimurium (ST) strain against Salmonella Typhimurium, Salmonella Gallinarum (SG), and Salmonella Enteritidis (SE) infection in layer chickens. Birds were orally primed with the attenuated ST strain at 7 days of age and then boosted at 4 weeks post prime immunization (PPI). Sequential monitoring of plasma IgG and mucosal secretory IgA (sIgA) levels revealed that inoculation with ST induced a significant antibody response to antigens against ST, SE, and SG. Moreover, significant lymphoproliferative responses to the 3 Salmonella serovars were observed in the immunized group. We also investigated protection against virulent ST, SE, and SG strain challenge. Upon virulent SG challenge, the immunized group showed significantly reduced mortality compared to the non-immunized group. The reduced persistence of the virulent ST and SE challenge strains in the liver, spleen, and cecal tissues of the immunized group suggests that immunization with the attenuated ST strain may not only protect against ST infection but can also confer cross protection against SE and SG infection.
Assuntos
Formação de Anticorpos , Aves , Galinhas , Proteção Cruzada , Imunização , Imunoglobulina A Secretora , Imunoglobulina G , Fígado , Mortalidade , Plasma , Salmonella enterica , Salmonella enteritidis , Salmonella typhimurium , Salmonella , BaçoRESUMO
Objective To prepare the bivalent immunoglobulin yolk (lgY) against eobra and viper venom and to detect its activities as the foundation for production and application of polyvalent . Methods The venom of Naja atra Cantor and Daboia russellii siamensis injected alternately into the leghorn hen. Biva-lent lgY was extraeted by water dilution. The biological activity of bivalent lgY were deteeted in several as-pects, sueh as the potency ( by indireet ELISA assay), the cross immunity ( by double immunodiffusion), the membrane lysis activity ( by experiments of vitelline membrane lysis) and 50% lethal activity ( LD50 ). Results Bivalent IgY was extracted from eggs yolk in 28-42 days after the first immunization. The titers of bivalent lgY against cobra and viper venom were 1:12 800 and 1: 6400. The cross immunologic reactions of bivalent IgY were found obviously with six kinds of snake venoms from Elapinae and Viperinae. There were not immunologic precipitation lines between bivalent IgY and four kinds of snake venoms from Crotalinae. Bi- valent lgY obviously deereased the vitelline membrane lysis activity of cobra and viper venom and prolonged the average survival time of mice with cobra or viper envenomation (P < 0.05). Moreover, with the same dose of bivalent IgY, the survival rate of mice with cobra venom envenomation was higher than those with vi-per venom envenomation. Conclusion Bivalent lgY could signifieantly neutralize biologieal activities of co-bra and viper venom, protect animals with cobra or viper envenomation.